Black Swan Research Initiative Continues to Take the Stage for Advances in Myeloma

n his blog this week, IMF Chairman Dr. Brian Durie reports on last week's symposium on “New Developments in MRD Diagnostics,” held in Zurich, Switzerland by the ESLHO (European Scientific Foundation of Laboratory Hemato Oncology). Conference panelists included Dr. Durie, who discussed MRD (minimal residual disease) and its role in the IMF's signature Black Swan Research Initiative (BSRI), and fellow BSRI investigators Drs. Alberto Orfao (in photo) and Bruno Paiva.
Source: International Myeloma Foundation - Category: Hematology Source Type: news